Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP TechnologyAnnika Olsson, Kaj Blennow, Hugo Vanderstichele et al.|Clinical Chemistry|2004Cited by 441
Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple‐system atrophy compared with Parkinson's diseaseBjörn Holmberg, Bo Johnels, Lars Rosengren et al.|Movement Disorders|1998Cited by 141
Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsyBjörn Holmberg, Lars Rosengren, Bo Johnels et al.|Movement Disorders|2002Cited by 105
Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical parkinsonian disordersRadu Constantinescu, Björn Holmberg, Lars Rosengren et al.|Parkinsonism & Related Disorders|2009Cited by 98
Levels of brain related proteins in cerebrospinal fluid: An aid in the differential diagnosis of parkinsonian disordersRadu Constantinescu, Lars Rosengren, Henrik Zetterberg et al.|Parkinsonism & Related Disorders|2008Cited by 65